Active Pharmaceutical Ingredients Market Analysis, Size, Growth, Share & Forecast to 2027 | Grand View Research Inc.
“Active Pharmaceutical Ingredients Market Worth $286.6 Billion By 2027”
The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. A steady rise in consumer demand for APIs, especially in developing and under-developed countries, increases the adoption of these products. In addition, strategic collaborations play a key role in the adoption of these ingredients in various regions. For instance, in February 2019, Cipla Inc. partnered with Wellthy Therapeutics Private Limited to combine digital therapeutics and pharmacotherapy for better patient outcomes in cardiovascular diseases and diabetes. Private and public initiatives to manufacture active pharmaceutical ingredients within their countries, especially in developing countries such as India, is expected to drive the growth of the market. For instance, API production in India is promoted under the “Make in India” initiative. Presence of prominent players and increasing government initiatives for the development of pharmaceuticals in various regions are also expected to boost the market growth. Increasing consumer awareness and demand for economical and effective treatment strategies, especially in Asia Pacific and Middle East and Africa, are driving the sales channels. In addition, high adoption and growing usage of online pharmacies are likely to drive the e-commerce sales of APIs.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceuticalingredients-market
Follow Us:
The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. For instance, in March 2019, Dr. Reddy’s Laboratories Ltd. launched XCEED-a B2B customer service portal. The platform was designed to manage the growing demand for generic active pharmaceutical ingredients by significantly increasing operational efficiency. Further key findings from the study suggest: On the basis of type of synthesis, the synthetic segment dominated the active pharmaceutical ingredients market in 2019 owing to easy availability of raw materials and easier protocols in place for the synthesis of these molecules
The biotech segment is estimated to register the highest CAGR owing to higher efficiency of these molecules and increasing demand for biopharmaceuticals
Captive manufacturers held the largest share in 2019 due to easy availability of raw materials
The merchant manufacturers segment is estimated to witness a lucrative CAGR over the forecast period
The generic segment is estimated to register the highest CAGR over the forecast period. The segment is driven by factors such as lower cost and expiration of patents of branded drugs
Asia Pacific is estimated to register a significant CAGR of 8.0% owing to the increasing number of pharmaceutical manufacturing plants in the region
Some of the key players in the API market are Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; AbbVie Inc.; Merck & Co., Inc.; Cipla Inc.; Albemarle Corporation; Dr. Reddy’s Laboratories Ltd.; Bristol-Myers Squibb Company; Aurobindo Pharma; and Sun Pharmaceutical Industries Ltd.
Grand View Research has segmented the global active pharmaceutical ingredients market on the bas is of type of synthesis, type of manufacturer, type, application, and region: API Type of Synthesis Outlook (Revenue, USD Billion, 2015 - 2027) Biotech
o
Monoclonal antibodies
o
Recombinant proteins
o
Vaccines
Synthetic
API Type of Manufacturer Outlook (Revenue, USD Billion, 2015 - 2027) Captive APIs
Merchant APIs
API Type Outlook (Revenue, USD Billion, 2015 - 2027) Generic APIs
Innovative APIs
Follow Us:
API Application Outlook (Revenue, USD Billion, 2015 - 2027) Cardiology
o
Generic
o
Innovative
Oncology o
Generic
o
Innovative
CNS & Neurology o
Generic
o
Innovative
Orthopedic o
Generic
o
Innovative
Endocrinology o
Generic
o
Innovative
Pulmonology o
Generic
o
Innovative
Gastroenterology o
Generic
o
Innovative
Nephrology o
Generic
o
Innovative
Ophthalmology o
Generic
o
Innovative
Others
API Regional Outlook (Revenue, USD Billion, 2015 - 2027) North America o
Follow Us:
U.S.
o
Canada
Europe o
Germany
o
U.K.
o
France
o
Italy
o
Spain
Asia Pacific o
China
o
Japan
o
India
o
Australia
o
South Korea
Latin America o
Mexico
o
Brazil
o
Argentina
MEA o
South Africa
o
Saudi Arabia
o
UAE
Table of Content Chapter 1 Methodology And Scope 1.1 Market Segmentation 1.2 Market Definition 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.4 Information Analysis
Follow Us:
1.4.1 Data Analysis Models 1.5 Market Formulation & Data Visualization 1.6 Validation & Publishing 1.7 Geographic Scope & Assumptions 1.8 Region-Wise Market Calculation 1.8.1 Region-Wise Market: Base Estimates 1.9 Market Cagr Calculation 1.9.1 Region Based Segment Share Calculation Chapter 2 Executive Summary 2.1 API Market Outlook 2.2 API Market: - Segment Outlook 2.3 API Market: -Competitive Insights 2.4 Market Summary Chapter 3 Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Outlook 3.2 Penetration And Growth Prospect Mapping Continue…………. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market y provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and factbased research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519
Follow Us:
Email:sales@grandviewresearch.com For More Information:http://www.grandviewresearch.com
Follow Us: